Pete Corish

BroadOak Capital Partners LLC (BroadOak Capital Partners) is a private equity firm founded in 2006 by Bill Snider and Lars Hanan. The firm is headquartered in Maryland.

BBI Diagnostics Group Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. The firm’s products include cell culture reagents, conjugates, depleted serum, disease state plasma, enzymes, finished kits, gold nanoparticles, monoclonal antibodies, normal serums, patient samples, polyclonal antibodies, recombinant antibodies, silver nanoparticles, biothreat and explosives antibodies. It’s services include custom conjugation, lateral flow assay development, 3DNA pushing assay sensitivity to the limit, test optimisation, atomo rapid platform and the novarum reader. The company was founded by John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.

Part of BBI Diagnostics Group Ltd., British Biocell International Ltd. is a private group led by Julian Baines. The company is based in Cardiff, UK. British Biocell International was acquired by BBI Diagnostics Group Ltd. on January 31, 2001.

Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

BBI Solutions OEM Ltd. develops and manufactures raw materials and finished test platforms for the in-vitro diagnostics market. It offers gold reagents, antibodies, antigens, biobank, cell culture, reagents, and enzymes. The firm services include lateral flow assay development, lateral flow test manufacture, and case studies. The company was founded in John Chandler in 1986 and is headquartered in Cardiff, the United Kingdom.